1 Beyond coverage decisions: Private health plans in the US and comparative effectiveness research Steven D. Pearson, MD, MSc, FRCP President, Institute.

Slides:



Advertisements
Similar presentations
What You Wanted to Know About Formularies Emmanuelle Mirsakov Pharm.D. Candidate 2007 USC School Of Pharmacy.
Advertisements

Containing Health Care Costs: Market Forces and Regulation Paul B. Ginsburg, Ph.D. Center for Studying Health System Change and National Institute for.
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Shared Decision Making – a strategic framework for commissioners 2 May 2012.
National Coalition for Cancer Survivorship Meeting, Washington DC November 13, 2014 Steven Clauser, PhD, MPA Program Director, Improving Healthcare Systems.
Solution in Drug Plan Management 2011 September 8, 2011 Basil Rowe Vice President, Total Rewards and Shared Services Shoppers Drug Mart
Value & Coverage Issue Brief Slides A Closer Look at Health Plan Coverage Policies and Approaches.
MaineCare’s New Medication Assisted Treatment (MAT)/Methadone Maintenance Therapy (MMT) Policy Kevin S. Flanigan, MD Medical Director Office of MaineCare.
SEBs: “What do patients say? Presented by Cheryl L. Koehn 2015 CADTH Symposium Saskatoon, Saskatchewan April 14, 2015.
Collaboration Across the Spectrum of Formularies in Saskatchewan: The RQHR Perspective Wm. Semchuk, MSc,PharmD,FCSHP Manager, Pharmacy Practice Regina.
Staff Health Care Committee Recommendations An update for UAA’s APT and Classified Staff Councils November 2009.
NICE in a changing world National Leading Improvement for Health and Well-being programme 12 May 2011 Gillian Mathews Implementation consultant.
Rwanda Social Security Board (RSSB) Medical Insurance Scheme May 2013.
Introducing NICE... Gateshead Council Gillian Mathews Implementation consultant - north.
Health Care Financing and Managed Care. Objectives  To understand the basics of health care financing in the United States  To understand the basic.
UW H EALTH P RIMARY C ARE / B EHAVIORAL H EALTH I NTEGRATION U NITED W AY F ORUM September 22,
Midwest Business Group on Health National Employer Survey on Biologics/Specialty Pharmacy August 2011.
Health Care Reform Cost Savings Julie Sonier Director, Health Economics Program Minnesota Department of Health SCI Summer Meeting July 31, 2008.
Provider Peer Grouping: Project Overview James I. Golden, PhD Director, Division of Health Policy Minnesota Department of Health SCI National Meeting May.
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
1 Evidence and the next stage of health care reform: Why consumer engagement is so important Steven D. Pearson, MD, MSc President, Institute for Clinical.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Janice Berry Edwards, PhD, LICSW, LCSW-C, BCD, ACSW
1 The Cancer Consortium Deborah Schrag, MD (PI) Caprice Christian Greenberg, MD, MPH Brigham and Women’s Hospital Dana-Farber Cancer Institute.
Prior Authorization Criteria for PDL Classes: Alzheimer’s Anti-emetics High Potency Statins Hormone Replacement Therapy Multiple Sclerosis – Tysabri Charles.
1 Using Comparative Effectiveness Research to Identify “Marginal Medicine” Steven D. Pearson, MD, MSc, FRCP.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
2010 NIAMS Scientific Retreat Comparative Effectiveness Research Institute of Medicine Priorities Functional Limitations & Disabilities Endocrinology &
CMS as a Public Health Agency: Effective Health Care Research Barry M. Straube, M.D. Centers for Medicare & Medicaid Services January 11, 2006.
Getting Evidence Based Psychosocial Treatments into Practice – Schizophrenia David L. Shern, Ph.D De la Parte Florida Mental Health Institute University.
1 Comparative Effectiveness Research: Key Issues and Controversies Consumer-Purchaser Disclosure Project Discussion Forum May 5, 2009 Steven D. Pearson,
Rhode Island’s Initiatives for Affordable Health Insurance August 3, 2006.
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
ACUTE-CRISIS PSYCHIATRIC SERVICES DEVELOPMENT INITIATIVE DC Hospital Association Department of Mental Health June 30, 2004.
Managed Care. In the broadest terms, Kongstvedt (1997) describes managed care as a system of healthcare delivery that tries to manage the cost of healthcare,
Pharmacy 483 Outcomes & Cost Management in Pharmacy Practice Janet Kelly, Pharm.D., BC-ADM February 24, 2004.
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
Asthma Management and the Allergist: Better Outcomes at Lower Cost.
Accountable Care: The Challenge of the Decade Michigan’s Premier Public Health Conference October 13, 2011 Kim Horn President and CEO Priority Health.
1 National Forum on Biomedical Imaging in Oncology CMS UPDATE Steve Phurrough MD, MPA Director, Coverage and Analysis Group.
Cost of Care Overview Payment Reform Subcommittee March 11, 2014.
Drug Formulary Development & Management
Health Care Connected: Next Generation Pharmacy February 13, 2016.
DANNA MAUCH, PHD PRESIDENT AND CEO MASSACHUSETTS ASSOCIATION FOR MENTAL HEALTH STATE POLICY ROUNDTABLE MASSACHUSETTS WOMEN IN GOVERNMENT (WIG) STATE HOUSE.
Pharmacy Benefit Management (PBM) 101
Presentation Developed for the Academy of Managed Care Pharmacy
A Cost-Effectiveness Analysis of Maternal Genotyping to Guide Treatment in Postnatal Patients.
Behavioral Health: Access Issues Allen J. Brenzel, M.D., MBA Medical Director, BHDID Cabinet for Health and Family Services.
Geographic Variation in Healthcare and Promotion of High-Value Care Margaret E. O’Kane November 10, 2010.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Renee Markus Hodin, JD Director, Integrated Care Advocacy Project
Managed Care Models: The Benefit vs. Cost Balance
Promoting consumer access to affordable Prescription drugs
Comparative Effectiveness Research: Key Issues and Controversies
NAMI Smarts for Advocacy Medication: Protecting Choice
How is WEA Trust Reclaiming Healthcare?
Neonatal Abstinence Syndrome (NAS) Program Overview
Drug Management Updates
Effectiveness of Care Measures
“The Integrator” Optimal Care for All our Members and Patients
New York State Collaborative Care Medicaid Program
Cascade Pacific Action Alliance
Systematic Reviews and Medical Policy Determinations
Specialty Pharmacy Management
HR Specialty Products & Services Catalogue Executive Summary
Dr Peter Groves MD FRCP Consultant Cardiologist
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
Provider Peer Grouping: Project Overview
SAMPLE ONLY Dominion Health Center: Your Community Healthcare Home (or another defining message) Dominion Health Center is a community health center.
Behavioral Health Identification, Treatment & Referral in Primary Care
Presentation transcript:

1 Beyond coverage decisions: Private health plans in the US and comparative effectiveness research Steven D. Pearson, MD, MSc, FRCP President, Institute for Clinical and Economic Review

2 USA

3 Health care quality is inconsistent 6-Fold Variation in Age-Adjusted Coronary Interventional Procedures Source: Wennberg et al, Dartmouth Atlas of Health Care

CER and the Seven Habits of Highly Effective Active Purchasers 1.Narrow your network 2.Change the system of care for the 1% and the 5% 3.Make prices a priority 4.Contract differently to change the dynamic with providers 5

CER and the Seven Habits of Highly Effective Active Purchasers 1.Narrow your network 2.Change the system of care for the 1% and the 5% 3.Make prices a priority 4.Contract differently to change the dynamic with providers 5.Develop better evidence on what really works 6.Use “active” coverage policies linked to evidence 7.Use evidence as a catalyst for collaborative efforts to improve value 6

Develop better evidence on what really works Comparative effectiveness research –Research comparing alternative care options to determine what works best for whom, under real- world conditions –Systematic review of existing published evidence PBAC, NICE, etc. –Generation of new evidence 7

New partnerships to generate evidence

Generating and using CER Wellpoint, 2008 – REAL WORLD EFFECTIVENESS OF ASTHMA CONTROLLER MEDICATIONS Analysis of claims data of more than 55,000 patients who had used asthma controller medications found: – Inhaled asthma medications could achieve the lowest rate of emergency room visits and inpatient hospitalizations, but… – Medication compliance was lower with inhaled medications than with oral medications, particularly among children. August, 2009 – WellPoint said its National Pharmacy and Therapeutics Committee "chose to keep the oral controller used by the vast majority of its members on the same preferred formulary tier and lift its prior authorization requirement." 9

CER and the Seven Habits of Highly Effective Active Purchasers Use “active” coverage policies linked to evidence –Coverage with evidence development PET for cancer CT angiography Drug eluting stents –Step edit policies Higher value options not being used Can limit by type of provider, number of doses, fail other options first 10

11 Using step edit policies Adalimumab (Humira) –“Prior approval is required for this drug” –Restricted to rheumatology with a dose limit of 40mg every other week: 1)for patients with a dx of rheumatoid arthritis, AND 2)when prescribed by a rheumatologist, AND 3)For patients who have tried and failed or have medical contraindications to methotrexate (at least a three month trial) –This specialty drug must be obtained through SpecialtyScripts Pharmacy

CER and the Seven Habits of Highly Effective Active Purchasers Use evidence as a catalyst for collaborative efforts to improve value –The Project to Improve Prostate Cancer Care –The New England Comparative Effectiveness Public Advisory Council At the root of these initiatives are independent, trustworthy reviews of comparative effectiveness evidence 12

13 The Project to Improve Prostate Cancer Care ICER review of treatment options for low-risk prostate cancer found –Good evidence for active surveillance –NO significant difference in outcomes between radiotherapy approaches IMRT, brachytherapy, and proton beam therapy with 3-5 times price differential Massachusetts coalition –Purchasers (employers) –Health plans –Integrated Provider Groups

Step 1: Document substantial variation 14

15 Step 2: Set a goal TodayThe Goal: 100% Shared Decisions

Step 3: Align efforts Explored “active” coverage policy with prior authorization or non-coverage but not feasible Explored changing prices paid but found prices embedded in larger contractual arrangements So coalition decided to develop a common patient decision guide as a community standard Health plans offered incentive to providers to document shared decision-making with decision guide 16

The New England Comparative Effectiveness Public Advisory Council

New England CEPAC Collaboration among –State health plans for the poor (Medicaid) –Private plans –Large physician-hospital groups –Patient groups Independent Council meets in public to discuss evidence reviews on effectiveness and COST, to vote on evidence, and to make recommendations for best practice and policy All stakeholders work together afterward to implement the findings 19

New England CEPAC: Topics and Impact Treatments for Attention-Deficit Hyperactivity Disorder (ADHD) –Shift to behavioral therapy for youngest children Treatment for severe depression –First-in-nation coverage for magnetic treatment Diagnosis of sleep apnea –Shift to home diagnosis (equivalent accuracy and lower cost) Community Health Workers –Identified best practices for training and integrating into health care teams Supplemental Screening for Women with Dense Breast Tissue 20

Breast Cancer Risk: New England Women w/Dense Breast Tissue & Negative Mammogram 22

Budget Impact of Supplemental Screening with MRI 23

CER and the Seven Habits of Highly Effective Active Purchasers 1.Narrow your network 2.Change the system of care for the 1% and the 5% 3.Make prices a priority 4.Contract differently to change the dynamic with providers 5.Develop better evidence on what really works 6.Use “active” coverage policies linked to evidence 7.Use evidence as a catalyst for collaborative efforts to improve value 24

25 Thank you Steve Pearson